NCT04908982View on ClinicalTrials.gov

Aspirin for the Prevention of Preeclampsia in Women With Stage 1 Hypertension

PHASE4UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 28, 2021

Primary Completion Date

May 31, 2023

Study Completion Date

May 31, 2023

Conditions
Pre-Eclampsia
Interventions
DRUG

Aspirin 81mg

81mg aspirin daily beginning between 12 and 16 weeks of pregnancy and continuing until delivery.

Trial Locations (1)

23507

RECRUITING

Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Eastern Virginia Medical School, Norfolk

Sponsors
All Listed Sponsors
collaborator

AMAG Pharmaceuticals, Inc.

INDUSTRY

lead

Eastern Virginia Medical School

OTHER